Illustration of a person being vaccinated against Covid-19. An injection has stimulated the production of different antibodies against proteins on the SARS-CoV-2 virus that causes Covid-19. The presence of the antibodies mean that the body is primed to attack the virus (blue) when it is next encountered, preventing disease. The first vaccine, developed by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG32175156
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
2019-cov2019-ncovantibodiesantibodyartworkbiologicalbiologyconceptsconceptualconditioncoronaviruscovid-19diseasedisorderepidemicgreybackgroundhcovhumanbodyillustrationimmuneresponseimmunesystemimmunisationimmunisingimmunityimmunizingimmunoglobulinimmunologicalimmunologyinjectinginjectionno-onenobodypandemicsars-covsars-cov-2vaccinatingvaccinationvaccineviralvirionvirusppepersonalprotectiveequipmentfacemaskfacemask
2019-cov2019-ncovantibodiesantibodyartworkbackgroundbiologicalbiologybodyconceptsconceptualconditioncoronaviruscovid-19diseasedisorderepidemicequipmentfacefacemaskgreyhcovhumanillustrationimmuneimmuneimmunisationimmunisingimmunityimmunizingimmunoglobulinimmunologicalimmunologyinjectinginjectionmaskno-onenobodypandemicpersonalppeprotectiveresponsesars-covsars-cov-2systemvaccinatingvaccinationvaccineviralvirionvirus